Penn Medicine Provider
Radiation Oncology
Keith Cengel, MD, PhD
5.0
(47)
Accepting new patients
Sees patients age 18 and up
Penn Radiation Oncology Perelman - 2nd Floor
View 2 additional locations

About me

  • Executive Director, Penn Mesothelioma and Pleural Diseases Program
  • Director, Photodynamic Therapy Program
  • Professor of Radiation Oncology at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: University of Illinois School of Medicine
  • Residency: University of Illinois
  • Residency: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
5.0

47 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

June 2025
5.0
5.0
all went well.
June 2025
5.0
5.0
great doctor. trust him with my life
January 2025
5.0
5.0
i cannot say enough great things about dr. cengel.
January 2025
5.0
5.0
dr. cengel is very knowledgeable and explains things well.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Chester County Hospital: Has privileges to treat patients in the hospital.
Dr. Cengel is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Friberg AM, Tan HS, Diffenderfer ES, Verginadis I, Kim MM, Cengel K, Wiersma R, Dong L, Koumenis C, Teo BK, Zou W. Physicochemical indication of the FLASH effect from shoot-through proton pencil beam scanning parameters delivered under ultra-high dose rates , Phys Med Biol, 70: 2025


Feigenberg SJ, Costabile F, Tanes C, Bittinger K, O'Connor R, Agarwal D, Skoufos G, Salaris S, Hatzigeorgiou A, Kostopoulos N, Lloyd S, Friedes C, Chen L, Yegya-Raman N, Cengel K, Levin W, Valentić B, Quarton T, Shestov AA, Berman A, Bradley J, Maity A, Koumenis C, Ben-Josef E, Facciabene A. Enhancing outcomes in medically inoperable early-stage NSCLC with gut-targeted antibiotics and stereotactic body radiotherapy: results from a randomized pilot study , J Immunother Cancer, 13: 2025,e011356


Jenna Rocchetti 1, Nikhil Yegya-Raman 1, Michelle Iocolano 1, William P Levin 1, Keith A Cengel 1, Jeffrey Bradley 1, Steven J Feigenberg 1, Cole Friedes 2 Salvage thoracic reirradiation for recurrent non-small cell lung cancer: Clinical efficacy and the impact of consolidative immunotherapy , Radiother Oncol : 2025


Seyyedeh Azar Oliaei Motlagh 1, François Vander Stappen 2, Michele M Kim 1, Rudi Labarbe 2, Lucian Hotoiu 2, Arnaud Pin 2, Rasmus Nilsson 3, Erik Traneus 3, Keith A Cengel 1, Wei Zou 1, Boon-Keng Kevin Teo 1, Lei Dong 1, Eric S Diffenderfer 1 Verification of dose and dose rate for quality assurance of spread-out-Bragg-peak proton FLASH radiotherapy using machine log files , Med Phys : 2025


Gwendolyn M Cramer 1, Richard W Davis 4th 1, Emmanouil Papasavvas 2, Astero Klampatsa 3, Joann M Miller 1, Shirron Carter 1, Ruth Ikpe 1, Min Yuan 1, Sandy Widura 2, R Sonali Majumdar 2, Sally McNulty 1, Mary Putt 4, Andrew V Kossenkov 2, Luis J Montaner 2, Sunil Singhal 5, Edmund K Moon 3, Steven M Albelda 3, Keith A Cengel 1, Theresa M Busch 1 PD-1 Blockade Mitigates Surgery-Induced Immunosuppression and Increases the Efficacy of Photodynamic Therapy for Pleural Mesothelioma , Cancer Res Commun, 5: 2025,841-856


Ioannis I Verginadis 1, Anastasia Velalopoulou 1, Michele M Kim 1, Kyle Kim 1, Ioannis Paraskevaidis 1, Brett Bell 2, Seyyedeh Azar Oliaei Motlagh 1, Antoneta Karaj 3, Esha Banerjee 4, Giovanni Finesso 4, Charles-Antoine Assenmacher 4, Enrico Radaelli 4, Jiawei Lu 5, Yuewei Lin 5, Mary E Putt 3, Eric S Diffenderfer 1, Chandan Guha 2, Ling Qin 5, James M Metz 1, Amit Maity 1, Keith A Cengel 1, Constantinos Koumenis 1, Theresa M Busch 6 FLASH proton reirradiation, with or without hypofractionation, reduces chronic toxicity in the normal murine intestine, skin, and bone , Radiother Oncol : 2025


Stalker M, Walker SL, Lebow E, Pai EL, Watts A, Hwang WT, Banihashemi A, Anderson E, Roshkovan L, Katz SI, Litzky L, Haas AR, Singhal S, Langer CJ, Cengel K, Marmarelis ME. Incidence and Outcomes of Brain Metastasis in Pleural Mesothelioma in the Era of Immunotherapy , JTO Clin Res Rep, 6: 2025,100823


Hongjing Sun 1 2, Michele M Kim 1, Yi Hong Ong 1, Andreea Dimofte 1, Sunil Singhal 3, Theresa M Busch 1, Keith A Cengel 1, Timothy C Zhu 1 Comprehensive reanalysis of light fluence distribution in pleural photodynamic therapy using standardized anatomical coordinates , Photochem Photobiol : 2025


Wang H, Yao L, Zhong L, Fang J, He Q, Busch TM, Cengel K, Qin L. Marrow adipogenic lineage precursors (MALPs) facilitate bone marrow recovery after chemotherapy , Bone: 2025


Cengel KA, Belal Z, Kim MM, Hagan S, Camps S, Kalinin A, Hsue W, Diffenderfer E, Garonna A, Tschabrunn C. Cardiorespiratory-gated cardiac proton radiotherapy using a novel ultrasound guidance system , Clin Transl Radiat Oncol, 51: 2024,100904


View all publications